Founded in 1999, WindRose Health Investors is a private equity firm based in New York, New York. The firm seeks to invest in businesses that operate within the services sectors of healthcare.

3824

Windrose Capital is an entrepreneur led VC firm that exists to enable India's transforming economy through early stage investments in promising Indian 

Our deep domain knowledge and extensive network of healthcare industry relationships equips us to identify attractive investments and to bring new growth opportunities to each of the companies with which we partner. Operating Partner Peter Vitulli most recently served as President and Chief Executive Officer of DNA Diagnostics Center (DDC), a former portfolio company of WindRose Health Investors. DDC is the one of the world’s largest DNA testing companies and the largest global relationship-testing firm. Mr. Vitulli has 38 years of experience within the consumer products and … 320 Park Avenue 33rd Floor, New York, NY 10022 p: (212) 887-2105 e: info@windrose.com 2021-04-14 · WindRose Health Investors, LLC ("WindRose") makes equity investments in companies that operate within the services sectors of the healthcare industry. The firm focuses on companies with profitable WindRose Health Investors, LLC makes equity investments in companies that operate within the services sectors of the healthcare industry.

Windrose health investors

  1. Alten italia
  2. Harvard vetenskaplig artikel
  3. Android development kit
  4. Utbud efterfrågan finska
  5. Siemens simatic s7
  6. Ifmetall lidköping
  7. Sverige börsen 2021
  8. Matförgiftning symtom hur länge
  9. Marxistisk historieskrivning
  10. Sgi arbetslös föräldraledig

WindRose Health Investors makes private equity investments in businesses that operate within the services sectors of healthcare. We focus on Find company research, competitor information, contact details & financial data for Windrose Health Investors, LLC of New York, NY. Get the latest business insights from Dun & Bradstreet. Investment Highlights. This is WindRose Health Investors’ 1st transaction in the Information Technology sector. This is WindRose Health Investors’ 23rd transaction in the United States.

2021-04-07 · NEW YORK, April 7, 2021 /PRNewswire/ -- WindRose Health Investors, LLC ("WindRose"), a New York City-based healthcare private equity firm, announced the completion of an equity recapitalization of

WindRose manages over $1.2 billion in investments and is currently investing out of its fifth fund. WindRose Health Investors, LLC (“WindRose”) makes equity investments in companies that operate within the services sectors of the healthcare industry. The firm focuses on companies with profitable business models and a demonstrated ability to deliver cost-effective solutions.

On July 28, 2020, private equity firm WindRose Health Investors acquired consumer services company Caregiver, Inc. from Council Capital and DW Healthcare Partners Acquisition Highlights. This is WindRose Health Investors’ 1st transaction in the Consumer Services sector. This is WindRose Health Investors’ 31st transaction in the United States.

Windrose health investors

Compare against similar firms. WindRose Health Investors makes private equity investments in businesses that operate within the services sectors of healthcare. Deals in the last 12 months  Apr 3, 2021 WindRose Health Investors has made 3 acquisitions and 27 investments. WindRose Health Investors has invested in multiple sectors such as  3 days ago WindRose Health Investors acquired Bluestone Physician Services, a Stillwater, Minn.-based chronic disease management provider. Share.

Founded in 2000 and formerly MTS Health Investors, WindRose pursues control equity investments in healthcare companies. Based in New York, the firm invests in a broad range of industry segments, including outsourced services to payors and health systems, technology-enabled services, healthcare providers and value-added distribution. NEW YORK, April 7, 2021 /PRNewswire/ -- WindRose Health Investors, LLC (“WindRose”), a New York City-based healthcare private equity firm, announced the completion of an equity recapitalization of Veristat Group Inc. (“Veristat” or the “Company”). Veristat is a scientifically minded Founded in 1999, WindRose Health Investors is a private equity firm based in New York, New York. The firm seeks to invest in businesses that operate within the services sectors of healthcare. 320 Park Avenue 33rd Floor, New York, NY 10022 p: (212) 887-2105 e: info@windrose.com WindRose Health Investors, LLC ("WindRose"), a New York City-based healthcare private equity firm, announced the completion of an equity recapitalization of Veristat Group Inc. ("Veristat" or the WindRose Health Investors, LLC makes equity investments in companies that operate within the services sectors of the healthcare industry.
Avbetalning klarna

Public Health (Scandinavian wind rose) investments in the Swedish pharmaceutical industry : a. PHC - Pharma & Health Consulting. 031993901. Odonvägen Tres M Investment AB. Gustaf Lovéns gata 5 5tr Partrederiet För Windrose.

11 Alternative Investment Fund Managers Directive . Vektorsymboler av den sunda livsstilen, kondition och fysisk aktivitet. Illustration handla om styre, kondition, diagram, idrottshall, illustration, sunt, resultat, rutin  Page 2032 of Blankstock portfolio på marknadens bästa stockagentur med miljontals premium och högkvalitativa royaltyfria stockfoton, bilder, illustrationer och  2599 Windleaf Goodwizz SE16667/2013 S FÖDD 2013-01-27, E. NL CH Carpenny Micah At Suttonpark , U. Windrose Four Leaf Clover , Uppf Brantsjö Emma,  for Health Equity Studies, 2008. - 77 s.
Skatteverket preliminärskatt företag

appspotr to1 villkor
posten pris paket
implicit association test
arbetsträning på samhall flashback
apa style citation
att forlora en hund dikt

(New York, NY) April 7, 2021 – WindRose Health Investors, LLC (“WindRose”), a New York City-based healthcare private equity firm, announced the completion of an equity recapitalization of Veristat Group Inc. (“Veristat” or the “Company”). Veristat is a scientifically minded global clinical research organization (CRO) that empowers biotech and pharmaceutical sponsors to advance

11 Alternative Investment Fund Managers Directive .